INDV Indivior Pharmaceuticals, Inc.
$34.49▼ -0.06%
Healthcare
Other
After hours
$34.49▲ +0.00%
Sep 11, 7:30 PM ET
Volume 1.29M
Avg Volume (10D) 1.89M
Key Metrics & Fundamentals
Market Cap
$4.07B
P/E Ratio
12.4
Div Yield
–%
52W Range
22.22 - 42.81
% vs 50 MA
-9.90%
% vs 200 MA
-3.28%
RSI-14
33.1
MACD Histogram
-0.0300
Beta (1Y vs SPY)
0.45
Free Cash Flow
$222.00M
Gross Rev
$343.00M
Gross Profit
$293.00M
EBITDA
$165.00M
COGS
$50.00M
Operating Exp
$134.00M
Operating Income
$159.00M
EBIT
$159.00M
Pretax Income
$160.00M
Net Income
$122.00M
EPS (Diluted)
0.98
Price & Volume History
Loading chart…
Recent News
Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound?
Zacks · Sep 2, 2026 3:30 PM
Indivior Pharmaceuticals Inc. (INDV) Loses 12.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks · Aug 31, 2026 1:35 PM
3 Reasons Why Growth Investors Shouldn't Overlook Indivior Pharmaceuticals Inc. (INDV)
Zacks · Aug 27, 2026 4:45 PM
Indivior Pharmaceuticals (INDV) Could Be 30% Undervalued On Its Cost Reset Plan
Simply Wall St. · Aug 22, 2026 2:11 AM
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
Zacks · Aug 21, 2026 4:40 PM
Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
Zacks · Aug 21, 2026 2:48 PM
Indivior Q2 Earnings Call Highlights
MarketBeat · Aug 3, 2026 2:04 PM
Supernus jumps premarket on merger deal; GameStop drops
Investing.com · Aug 3, 2026 12:22 PM
Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
GlobeNewswire · Aug 3, 2026 10:31 AM
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
GlobeNewswire · Aug 3, 2026 10:30 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See INDV's money flow as a full page
Social Sentiment
Avg +0.45 · 2 posts
TradeDiscussionStarting a savings for a family member - $20-$25K
r/investing · Jul 18, 2025
The author confirms they already hold and invest in INDV, indicating a positive sentiment towards the stock.
positive
+0.50
These are the stocks on my watchlist (7/9)
r/stocks · Jul 9, 2024
The profit warning and discontinuation of a drug are negative indicators for the company's future prospects, suggesting a cautious stance.
negative
+0.40
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.